 vs benefits of
periprocedural retrievable inferior vena cava placement
be considered in patients undergoing pharmacomechanical thrombolysis and in those with thrombus
extending into the inferior vena cava or who have
markedly limited cardiopulmonary reserve (Grade 2
C). Although the routine use of IVC filters in patients
undergoing catheter-directed pharmacologic thrombolysis appears to be unwarranted, the selective use of such
devices in